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Background: The continuous spread of multidrug-resistant (MDR) bacteria, partially due to efflux pumps drastically
reduced the efficacy of the antibiotic armory, increasing the frequency of therapeutic failure. The search for new
compounds to potentiate the efficacy of commonly used antibiotics is therefore important. The present study was
designed to evaluate the ability of the methanol extracts of four Cameroonian dietary plants (Capsicum frutescens
L. var. facilulatum, Brassica oleacera L. var. italica, Brassica oleacera L. var. butyris and Basilicum polystachyon (L.)
Moench.) to improve the activity of commonly used antibiotics against MDR Gram-negative bacteria expressing
active efflux pumps.
Methods: The qualitative phytochemical screening of the plant extracts was performed using standard methods
whilst the antibacterial activity was performed by broth micro-dilution method.
Results: All the studied plant extracts revealed the presence of alkaloids, phenols, flavonoids, triterpenes and
sterols. The minimal inhibitory concentrations (MIC) of the studied extracts ranged from 256-1024 μg/mL. Capsicum
frutescens var. facilulatum extract displayed the largest spectrum of activity (73%) against the tested bacterial strains
whilst the lower MIC value (256 μg/mL) was recorded with Basilicum polystachyon against E. aerogenes ATCC 13048
and P. stuartii ATCC 29916. In the presence of PAβN, the spectrum of activity of Brassica oleacera var. italica extract
against bacteria strains increased (75%). The extracts from Brassica oleacera var. butyris, Brassica oleacera var. italica,
Capsicum frutescens var. facilulatum and Basilicum polystachyon showed synergistic effects (FIC ≤ 0.5) against the
studied bacteria, with an average of 75.3% of the tested antibiotics.
Conclusion: These results provide promising information for the potential use of the tested plants alone or in
combination with some commonly used antibiotics in the fight against MDR Gram-negative bacteria.
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The spread of multidrug-resistant bacteria, partially due
to the inappropriate use of common antibiotics, drastically
reduced the efficacy of the antibiotic armory, increasing the
frequency of therapeutic failure. The over-expression of ef-
flux pumps is the main resistance mechanism observed in
many bacteria [1]. In Gram-negative bacteria, many of these
efflux pumps belong to the resistance-nodulation-cell* Correspondence: kuetevictor@yahoo.fr
Department of Biochemistry, Faculty of Science, University of Dschang, P.O.
Box 67, Dschang, Cameroon
© 2014 Touani et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.division (RND), family of tripartite efflux pumps [2]. In
the fight against microbial infections including those
due to MDR bacteria, investigations are being carried out
to discover new effective, none or less-toxic and available
antibacterial drugs. Many scientist are also investigating
synergistic compounds to potentiate the activity of the
commonly used antibiotics [3]. The present work was
designed to evaluate the in vitro ability of some edible
plants namely Capsicum frutescens L. var. facilulatum
(Solanaceae) or ‘chili pepper’, Brassica oleacera L. var.
italica commonly known as ‘Broccoli’ and BrassicaLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 2 Extraction yields and phytochemical composition











Yield* (%) 7.22% 12.18% 7.31% 8.61%







Alkaloids + + + +
Anthocyanins - - - -
Anthraquinones - - - -
Flavonoids + + + +
Phenols + + + +
Coumarins - - - +
Tannins - + + -
Triterpenes + + + +
Sterols + + + +
Saponins - + - +
(+): Present; (-): Absent; *yield calculated as the ratio of the mass of the
obtained methanol extract/mass of the plant powder.
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and Basilicum polystachyon (L.) Moench. (Lamiaceae) or
‘Musk Basil’ to potentiate the effect of common antibiotics
against Gram-negative MDR phenotypes.
Methods
Plant material and extraction
The plants used in this study were collected in Douala
(Littoral Region of Cameroon) in January 2013. The
plants were further identified at the National Herbarium
(Yaoundé, Cameroon) where voucher specimens were
deposited under a reference number (Table 1). Air dried
and powdered sample (0.1 g) of each plant was extracted
by maceration with methanol (0.3 L) for 48 h at room
temperature (25°C). After filtration using Whatman No. 1
filter paper, the filtrate of each plant was concentrated
under reduced pressure in a rotary evaporator, and dried
at room temperature to give the crude extract. The extrac-
tion yield was calculated (Table 2). These extracts were then
stored at 4°C until further use.
Preliminary phytochemical screenings
The secondary metabolite classes such as alkaloids,
anthocyanins, anthraquinones, flavonoids, phenols, sa-
ponins, tannins, sterols and triterpenes were screened
according to the standard phytochemical methods de-
scribed by Harbone [16].
Bacteria strains and culture media
The studied microorganisms included both reference
(from the American Type Culture Collection, ATCC) and
clinical (Laboratory collection) strains of Escherichia coli,
Enterobacter aerogenes, Providencia stuartii, Pseudomonas
aeruginosa and Klebsiella pneumoniae (Table 3). They were
maintained at 4°C and sub-cultured on a fresh appropriateTable 1 Information on plants used in this study
Plants samples and herbarium
voucher numbera
Parts used Popular names Traditio
Capsicum frutescens L. var.
facilulatum (Solanaceae)
43079/HNC
Fruits Green pepper Antimito
allergy, c
viral infe




Brassica oleacera L. var. butyris
(Brassicaceae) 25686/SFR Cam









Af, Fm Ca, Tm, Tr, Tt, Mc, Sa, Bc, Ec, Pa, Sc, Te Hm, Pm, Pp, Lm, Lp, Lb, Lm, Bs, Ea, St
moniliforme, Candidat albicans, trichophyton mentagrophytes, T. rubum, T.tonsuraus M
Pseudomonas aeroginosa, Saccharomyces cerevisiae, Torulopsis etchellsii, Hansenula m
mesenteroides, Lactobacillus plantarum , Lactobacillus brevis, Listeria monocytogenes,
etchellsii, Hansenula mrakii, Aspergillus niger, Klebsiella pneumoniae CI, Enterobacter c
Allyisothyocyanate, MMTS02: Méthylmethanethiosulfonat. SRFC: Company of ForestMueller Hinton Agar (MHA) for 24 h before any anti-
bacterial test. The Mueller Hinton Broth (MHB) was
used for all antibacterial assays.
Chemicals for antibacterial assays
Nine commonly used antibiotics including tetracycline
(TET), cefepime (CEP), streptomycin (STR), ciprofloxacin
(CIP), norfloxacin (NOR), chloramphenicol (CHL), ampi-
cillin (AMP), erythromycin (ERY), kanamycin (KAN)
(Sigma-Aldrich, St Quentin Fallavier, France) were used
for potentiation assay. p-Iodonitrotetrazolium chloride




Antibacterial activities of aqueous and methanolic extracts
against Sa, St, Vc [6,7], antifungal activities of lectin against
Af, [8]; antifungal activities of saponin CAY-1 against Ca,
Aspergillus Spp and dermatophytes Tm, Tr et Mc [9]
e stress,
c [10]
Antibacterial activities of ethanolic extractsagainst Sa, Bc,




Antibacterial activities of sulfur compounds MMTSO, AITC,
MMTSO2 against Pp, Lm, Lp, Lb Lm Sa, Ea, Ec, Bs, St and
antifungal against strains Sc, Te, Hm, Pm [12].
s diseases,
teritis [14].
Strong activities of acidic extracts against Gram (+), but
less activities against Gram;. Strong antifungal activities
of ethanolic and methanolic extracts against An [15].
, Te, Hm, An, Kp, Ec, Sm, Vc who are respectively : Aspergillus flavus, Fusarium
icrosporum canis, Staphylococcus aureus, Bacillus cereus, Escherichia coli,
rakii, Pichia membranefaciens, Pediococcus pentosaceus, Leuconostoc
Bacillus subtilis, Enterobacter aerogenes, Salmonella. Typhimurium, Torulopsis
loacae CI, CIv Vibrio cholerae MMTSO: Méthylmethanethiosulfinate, AITC:
Reserve of Cameroon; HNC: Cameroon National Herbarium.
Table 3 Bacterial strains and features
Bacteria and strains Features References
Escherichia coli ATCC 8739 References strains
ATCC 10536 References strains
AG100 Atet AG 100 sur-expressing AcrAB pumps, contaning TETR gène acrF [14]
AG100 Wild-typeE. ColiK-12 [15]
AG102 AG100 Sur-exprissingAcrAB pumps. [17]
MC4100 Wild typeE. coli
Enterobacter aerogenes ATCC 13048 References strains
EA27 Clinical MDR isolate exhibiting energy-dependent norfloxacin
and chloramphenicol efflux with KANR AMPR NALR STRR TETR
[18]
EA-3 Clinical MDR isolate CHLR, NORR, OFXR, SPXR, MOXR, CFTR, ATMR, FEPR [18]
EA 289 KAN sensitive derivative d’EA27 [18]
EA 294 EA289 sur-expressing AcrA pumps Exhibiting KANR [18]
EA 298 EA289 TolC KANR [18]
CM64 CHLRresistant variant obtained from ATCC13048 over-expressing
the AcrAB pump
[18]
Klebsiella pneumoniae ATCC 11296 References strains
K-2 Clinical MDR isolate exhibiting energy-dependent norfloxacin
and chloramphenicol efflux with KANR AMPR NALR STRR TETR
Laboratory collection of UNR-MD1,
University of Marseille, France
K-24 AcrAB-Tolc
KP 55 Clinical isolate MDR, TETR, AMPR, ATMR, CEFR [17]
KP 63 Clinical isolate du MDR, TETR, CHLRAMPR, ATMR [17]
Pseudomonas aeruginosa PA01 References strains
PA124 MDR Clinical isolate [15]
Providencia stuartii ATCC 29916 References strains
NAE16 MDR clinical isolate AcrAB-TolC [15]
aAMP, ATMR, CEFR, CFTR, CHLR, FEPR, KANR, MOXR, STRR, TETR. Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, cefepime, kanamycin,
moxalactam, streptomycin, and tetracycline; OMPF and OMPC: Outer Membran Protein F and C respectively. AcrAB-Tol: Efflux pump of type AcrAB associated to
one porine of type TolC.
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cator and efflux pumps inhibitor respectively. Dimethylsulf-
oxide 10% (DMSO) was used as solvent for all extracts.
Bacterial susceptibility determinations
The minimal inhibitory concentrations (MIC) of the plant
extracts against the studied bacteria were determined by
rapid INT colorimetric assay [19,20]. Briefly, the test sam-
ples were first dissolved in DMSO/MHB. The solution ob-
tained was then added to MHB in a 96-well microplate
followed by a two fold serial dilution. One hundred micro-
liters (100 μL) of inoculum (1.5 × 106 CFU/mL) prepared
in MHB was then added. The plates were covered with a
sterile plate sealer, then agitated to mix the contents of the
wells using a shaker and incubated at 37°C for 18 h. The
final concentration ranges were 8-1024 μg/mL for plant ex-
tracts and 2-512 μg/mL for reference antibiotic chloram-
phenicol (CHL). Wells containing MHB (100 μL), 100 μL
of inoculum and DMSO at a final concentration of 2.5%
served as negative growth inhibition control. MIC was de-
tected after 18 h of incubation at 37°C, following addition(40 μL) of 0.2 mg/mL INT and incubation at 37°C for
30 min. Viable bacteria reduced the yellow dye to pink.
MIC was defined as the lowest sample concentration that
prevented this change and exhibited complete inhibition
of bacterial growth [21]. The minimal bactericidal concen-
trations (MBC) of the samples was determined by taking
50 μL of the suspensions from the wells which did not
show any growth after incubation during MIC assays to a
new 96-well microplate containing 150 μL of fresh broth
per well. The plate was further re-incubated at 37°C for
48 hours the addition of INT. The MBC was defined as
the lowest concentration of samples which completely
inhibited the growth of bacteria. Samples were tested
alone and in the presence of PAβN at 30 μg/mL final
concentration [22].
To evaluate the potentiating effect of tested extracts, a
preliminary combination at their sub-inhibitory concen-
trations (MIC/2, MIC/5, MIC/10 and MIC/20) with anti-
biotics was assessed against P. aeruginosa PA124 strain.
The appropriate sub-inhibitory concentrations were then
selected on the basis of their ability to improve the activity
Touani et al. BMC Complementary and Alternative Medicine 2014, 14:258 Page 4 of 8
http://www.biomedcentral.com/1472-6882/14/258of the maximum antibiotic. These sub-inhibitory concen-
trations for selected extracts were further tested in com-
bination with antibiotics against more MDR bacteria. The
Fractional inhibitory concentration (FIC) of each combin-
ation was then calculated as the ratio of MIC of Antibiotic
in combination versus MIC of Antibiotic alone [23,24].
Results
Phytochemical composition of the tested plant’s extracts
The results of the qualitative phytochemical analysis showed
that each of the studied extract contained alkaloids, phenols,
flavonoids, triterpenes and sterols. None of them contained
anthocyanins and anthraquinones. Other phytochemical
classes have been selectively detected as shown in Table 2.
Antibacterial activity of the plant’s extracts
Bacterial strains and MDR isolates were tested for their
susceptibility to plant extracts and chloramphenicol. The
results summarized in Table 4 the selectivity of the extracts
towards the tested bacteria, with MIC values ranging
from 256 to 1024 μg/mL on the majority of the 22 tested






Escherichia coli ATCC 8739 - - 1024
ATCC 10536 512 - -
AG100 Atet 512 - 1024
AG100 - - -
AG102 1024 - -
MC4100 1024 - 512
Enterobacter aerogenes ATCC 13048 1024 - 1024
EA27 - - -
EA-3 1024 - -
EA294 - - -
EA298 512 - -
EA 289 1024 - -
CM64 1024 - -
Klebsiella pneumoniae ATCC 11296 1024 - 1024
K-2 512 - -
K-24 1024 - -
KP 55 1024 - -
KP 63 512 - -
Pseudomonas aeruginosa PA01 - - -
PA124 - - -
Providencia stuartii ATCC 29916 1024 - 1024
NAE16 1024 - -
NT: Not determined; -: superior to 1024 μL for extracts and superior to 512 μg/mL f
for the plant extracts.the largest spectrum of activity, 73% (16/22) against
the tested bacteria; followed by Brassica oleacera var.
italica, 50% (11/22); Basilicum polystachyon 41% (9/22)
and Brassica oleacera var. butyris 27% (6/22) extracts.
The lowest MIC value (256 μg/mL) was recorded with
Basilicum polystachyon extract against P. stuartii (ATCC
29916) and E. aerogenes (ATCC 13048). No significant
MBC value was recorded.
Eight (8) of the twenty two (22) studied MDR bacteria
were also tested for their susceptibility to the plant extracts
in the presence of PAβN (Table 5). The largest spectrum of
activity was recorded with B. oleacera var. butyris extract
against 75% (6/8) tested MDR bacteria. This efflux pumps
inhibitor (EPI) also improved the activity of C. frutescens
extract against E. coli (AG100), K. pneumoniae (KP53)
and E. aerogenes (EA27) as well as that of B. polystachyon
against P. stuartii (NAE16).
Antibacterial activity of extract-antibiotic combination
A preliminary assay against P. aeruginosa PA124 strain
allowed selecting MIC/2 and MIC/5 as appropriate sub-








MBC MIC MBC MIC MBC MIC MBC
- - - - - 8 512
- 1024 - - - 2 128
- 1024 - 512 1024 64 64
- - - - - 16 128
- 1024 - 1024 - 8 -
- 512 - 1024 - 128 128
- 1024 - 256 - 8 32
- - - - - 256 NT
- 1024 - 1024 - - -
- - - - - 256 512
- - - - - 4 16
- - - - - 128 -
- 1024 - - - 128 -
- 1024 - - - 8 512
- 1024 - 512 - 64 NT
- 1024 - 1024 - 16 256
- - - 512 - 32 -
- - - - - 128 NT
- - - - - 64 NT
- - - - - 512 NT
- 1024 - 256 - 4 32
- - - - - 256 NT
or antibiotics; CHL: Chloramphenicol; Values in Bold are the lowest MIC values
Table 5 Antibacterial activities of extracts alone and in the presence of PAβN
Bacterial strains Capsicum frutescens Brassica oleacera var. butyris Brassica oleacera var. italica Basilicum polystachyon CHL PAβN
AG100 1024 (256) - (1024) - (1024) - (-) 16 (4) >128
AG100 Atet 512 (512) 1024 (512) 1024 (1024) - (-) 64(32) >128
CM64 1024 (1024) - (-) 1024 (512) 1024 (1024) 128 (64) >128
EA27 - (512) - (128) - (512) - (-) 256 (64) >128
KP55 - (-) - (1024) - (1024) - (-) 64(8) >128
KP63 512 (256) - (1024) - (-) - (-) 128(16) >128
PA124 - (-) - (-) - (-) - (-) 512(128) >128
NAE16 - (-) - (1024) - (-) - (1024) 256(64) >128
( ): MIC value of extract in presence of PAβN; -: >1024 μg/mL for extracts and >512 μg/mL for antibiotic; CHL: Chloramphenicol.
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tested extracts. Brassica oleacera var. italica and B. oleacera
var. butyris extracts potentiate (0.125 < FIC < 0.5 and
0.031 < FIC < 0.5 respectively) the effects of the majority of
antibiotics on most of the tested MDR bacteria (Table 7).
Extracts from C. frutescens and B. polystachyon showed
synergistic effects with six of the nine studied antibiotics,
with 0.125 < FIC < 0.5 and 0.25 < FIC < 0.5 respectively.
Discussion
The Pharmacological potencies of plants’ secondary metab-
olites are well demonstrated. The qualitative phytochemical
screening of the plant extracts showed the presence of
several classes of secondary metabolites, such as alkaloids,
flavonoids, phenols, triterpenes, sterols, saponins, tanninsTable 6 MICs of antibiotics in combination with plant extract
Plants’ extracts CEF AMP CIP ERY
ATB ALONE - (-) - (-) 64 512
Capsicum frutescens MIC/2 - (-) - (-) 32 (0,5)S 256 (
MIC/5 - (-) - (-) 32 (0,5)S 256(0
MIC/10 - (-) - (-) 32 (0,5)S 256 (
MIC/20 - (-) - (-) 64 (1)1 256 (
Brassica oleacera var. butyris MIC/2 - (-) - (-) 32 (0,5)S 256 (
MIC/5 - (-) - (-) 32(0,5)S 256 (
MIC/10 - (-) - (-) 32(0,5)S 256 (
MIC/20 - (-) - (-) 32 (0,5)S 256 (
Brassica oleacera var. Italica MIC/2 - (-) - (-) 32 (0,5)S 256 (
MIC/5 - (-) - (-) 64(1)1 256 (
MIC/10 - (-) - (-) 64 (1)1 256 (
MIC/20 - (-) - (-) 64(1)1 256 (
Basilicum polystachyon MIC/2 - (-) - (-) 32 (0,5)S 128 (
MIC/5 - (-) - (-) 32 (0,5)S 256 (
MIC/10 - (-) - (-) 64 (1)1 256 (
MIC/20 - (-) - (-) 64 (1)1 256 (
s: Synergy; 1: Indifference; A: Antagonism; ( ): fractional inhibitory concentration or F
CHL: Chloramphenicol, STR: Streptomycin, TET: Tetracycline, KAN: Kanamycin, ERY: Er
the cases of synergy between extract and antibiotic.and coumarins. Several antibacterial activities associated
to the presence of compounds belonging to these vari-
ous classes were shown [25-27]. It should however be
mentioned that the detection of an alleged bioactive class
of secondary metabolite in a plant is not a guarantee for
any biological property, as this will depend on the nature
of the compounds as well as their concentrations and
the possible interactions with other constituents [12].
The differences observed between the antibacterial ac-
tivities of the extracts as observed in the present work
could be due to the differences in their phytochemical
composition [9]. According to the criteria of classifica-
tion of the antibacterial activity of the phytochemicals
[28], the extracts used in this study were moderately
and/or weak active (256 ≤MIC < 1024 μg/mL). Their directs against P. aeruginosa PA124
KAN TET STR CHL NOR
128 64 64 512 256
0,5)S 128 (1)1 32 (0,5)S 256 (4)1 256 (0,5)S 128 (0,5)S
,5)S 128 (1)1 64 (1)1 256 (4)1 256 (0,5)S 128 (0,5)S
0,5)S 128 (1)1 64 (1)1 256 (4)1 256 (0,5)S 128 (0,5)S
0,5)S 256 (2)1 64 (1)1 256(4)1 256 (0,5)S 128 (0,5)S
0,5)S 16 (0,125)S 16 (0,25)S 32 (0,5)S 256 (0,5)S 128 (0,5)S
0,5)S 16 (0,125)S 16 (0,25)S 32 (0,5)S 256 (0,5)S 128 (0,5)S
0,5)S 16 (0,125)S 32 (0,25)S 32 (0,5)S 256 (0,5)S 128 (0,5)S
0,5)S 32 (0,25)S 32 (0,25)S 64 (1)1 256 (0,5)S 128 (0,5)S
0,5)S 128 (1)1 32 (0,25)S 32 (0,5)S 256 (0,5)S 128 (0,5)S
0,5)S 128 (1)1 32 (0,25)S 32 (0,5)S 256 (0,5)S 128 (0,5)S
0,5)S 128 (1)1 32 (0,25)S 64 (1)1 512 (1)1 256 (1)1
0,5)S 128 (1)1 64 (1)1 64 (1)1 512 (1)1 256 (1)1
0,25)S 256(2)1 64 (1)1 64(1)1 256 (0,5)S 256 (1)1
0,5)S 256 (2)1 64 (1)1 64( 1)1 256 (0,5)S 256 (1)1
0,5)S 256 (2)1 64 (1)1 64 (1)1 256 (0,5)S 256 (1)1
0,5)S 256 (2)1 64 (1)1 64 (1)1 256 (0,5)S 256 (1)1
IC; -: MIC > 512 μg/mL; ATB: Antibiotic; CIP: Ciprofloxacin, NOR: Norfloxacin,
ythromycin, AMP: Ampicillin and CEF: Cefepime; The values in bold represent
Table 7 MIC of antibiotics in combination with plant at their MIC/2 and MIC/5 against selected MDR bacteria strains











MIC MIC/2 MIC/5 MIC/2 MIC/5 MIC/2 MIC/5 MIC/2 MIC/5
CEF AG100 - - - - - - - - -
EA27 256 - - - - 128 (0.5) s 256 (1)1 256 (1)1 256 (1)1
CM64 - - - - - - - - -
KP55 - - - - - - - - -
KP63 - - - - - - - - -
NAE16 - - - - - - - - -
PA124
AMP AG100 - - - - - - - - -
EA27 - - - - - - - - -
CM64 - - - - - - - - -
KP55 - - - - - - - - -
KP63 - - - - - - - - -
NAE16 - - - - - - - - -
CIP AG100 32 32 (1)I 64 (2)1 8 (0.25)S 8 (0.25)S 64 (2)1 64 (2)I 64 (2)1 128 (4)1
EA27 16 32 (2)1 32 (2)1 4 (0.25)S 4 (0.25)S 8 (0.5)S 8 (0.5)S 128 (8)A 128 (8)A
CM64 16 16 (1)I 16 (1)I 16 (1)I 16 (1)I 16 (1)I 16 (1)I 64 (4)1 128 (8)A
KP55 16 4 (0.25)S 8 (0.5)S 2 (0.125)S 4 (0.25)S 4 (0.25)S 16 (1)I 8 (0.5)S 8 (0.5)S
KP63 8* 4 (0.5)S 4 (0.5)S 1* (0.125)S 1* (0.125)S 1 (0.125)S 4 (0.25)S 16 (1)I 16 (1)I
NAE16 8* 2 (0.25)S 2 (0.25)S 2* (0.25)S 2* (0.25)S 2 (0.25)S 2 (0.25)S 8* (1)I 8 (1)I
PA124 64 32 (0.5)S 32 (0.5)S 32 (0.5)S 32 (0.5)S 32 (0.5)S 64 (1)1 32 (0.5)S 32 (0.5)S
ERY AG100 32 16 (0.5)S 16 (0.5)S 8 (0.25)S 8 (0.25)S 16 (0.5)S 16 (0.5)S 64 (2)1 64 (2)1
EA27 32 32 (1)I 32 (1)I 64 (2)1 64 (2)1 64 (2)1 64 (2)1 64 (2)1 64 (2)1
CM64 32 64 (2)1 16 (0.5)S 32 (1)I 32 (1)I 32 (1)I 32 (1)I 64 (2)1 64 (2)1
KP55 128 128 (1)I 128 (1)I 64 (0.5)S 64 (0.5)S 64 (0.5)S 128 (1)I 256 (2)1 256 (2)1
KP63 128 32 (0.25)S 64 (0.5)S 32 (0.25)S 64 (0.5)S 64 (0.5)S 64 (0.5)S 256 (2)1 256 (2)1
NAE16 128 16 (0.125)S 16 (0.125)S 32 (0.25)S 64 (0.5)S 128 (1)I 128 (1)I 256 (2)1 256 (2)1
PA124 512 256 (0.5)S 256 (0.5)S 256 0.5)S 256 (0.5)S 256 (0.5)S 256 (0.5)S 128 (0.25)S 256 0.5)S
KAN AG100 32 32 (1)I 64 (2)1 16 (0.5)S 16 (0.5)S 32 (1)I 32 (1)I 32 (1)I 32 (1)I
EA27 32 8 (0.25)S 8 (0.25)S 8 (0.25)S 8 (0.25)S 16 (0.5)S 16 (0.25)S 64 (2)1 64 (2)1
CM64 64 64 (1)I 64 (1)I 16 (0.25)S 32 (0.5)S 32 (0.5)S 32 (0.5)S 32 (0.5)S 32 (0.5)S
KP55 64 16 (0.25)S 16 (0.25)S 16 (0.25)S 16 (0.25)S 16 (0.25)S 16 (0.25)S 16 (0.25)S 16 (0.25)S
KP63 64 64 (1)I 64 (1)I 16 (0.25)S 16 (0.25)S 16 (0.25)S 32 (0.5)S 32 (0.5)S 32 (0.5)S
NAE16 64 64 (1)I 64 (1)I 32 (0.5)S 32 (0.5)S 64 (1)I 64 (1)I 64 (1)I 64 (1)I
PA124 128 128 (1)I 128 (1)I 16 (0.125)S 16 (0.125)S 128 (1)I 128 (1)I 256 (2)1 256 (2)1
TET AG100 32 8 (0.25)S 8 (0.25)S 16 (0.5)S 16 (0.5)S 4 (0.25)S 4 (0.125)S 16 (0.5)S 32 (1)I
EA27 128 64 (0.5)S 64 (0.5)S 16 (0.125)S 16 (0.125)S 4 (0.031)S 32 (0.25)S 64 (0.5)S 64 (0.5)S
CM64 64 128 (2)1 128 (2)1 4 (0.062)S 8 (0.125)S 64 (1)I 64 (1)I 128 (2)1 256 (4)1
KP55 16 2 (0.125)S 4 (0.25)S 1 (0.062)S 1 (0.062)S 2 (0.125)S 2 (0.125)S 16 (1)I 16 (1)I
KP63 32 8 (0.25)S 8 (0.25)S 8 (0.25)S 16 (0.5)S 16 (0.5)S 8 (0.25)S 16 (0.5)S 16 (0.5)S
NAE16 128 64 (0.5)S 64 (0.5)S 128 (1)I 128 (1)I 64 (0.5)S 64 (0.5)S - -
PA124 64 32 (0.5)S 64 (1)I 16 (0.25)S 16 (0.25)S 32 (0.5)S 32 (0.5)S 64 (1)I 64 (1)I
STR AG100 64 256 (4)1 256 (4)1 128 (1)I 128 (1)I 64 (0.5)S 128 (1)I 128 (1)I 128 (1)I
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Table 7 MIC of antibiotics in combination with plant at their MIC/2 and MIC/5 against selected MDR bacteria strains
(Continued)
EA27 8 32 (4)1 32 (4)1 4 (0.5)S 8 (1)I 2 (0.25)S 2 (0.5)S 8 (1)I 8 (1)I
CM64 64 256 (4)1 256 (4)1 8 (0.125)S 16 (0.5)S 16 (0.5)S 16 (0.5)S 64 (1)I 64 (1)I
KP55 16 32 (4)1 32 (4)1 16 (1)I 16 (1)I 16 (1)I 16 (1)I 16 (1)I 16 (1)I
KP63 64 256 (4)1 256 (4)1 128 (1)I 128 (1)I 128 (1)I 128 (1)I 128 (1)I 128 (1)I
NAE16 64 256 (4)1 256 (4)1 64 (0.5)S 64 (0.5)S 64 (0.5)S 64 (0.5)S 128 (1)I 128 (1)I
PA124 64 256 (4)1 256 (4)1 32 (0.5)S 32 (0.5)S 32 (0.5)S 32 (0.5)S 64 (1)I 64 (1)I
CHL AG100 16 4 (0.25)S 4 (0.25)S 4 (0.25)S 4 (0.25)S 16 (1)I 16 (1)I 16 (1)I 16 (1)I
EA27 256 - - 64 (0.25)S 128 (0.5)S 32 (0.125)S 64 (0.25)S 256 (1)I 256 (1)I
CM64 128 32 (0.25)S 32 (0.25)S 16 (0.125)S 16 (0.125)S 64 (0.5)S 64 (0.5)S 256 (2)1 256 (2)1
KP55 64 32 (0.5)S 32 (0.5)S 16 (0.25)S 32 (0.5)S 32 (0.5)S 32 (0.5)S 64(1)1 64 (1)1
KP63 128 128 (1)I 128 (1)I 64 (0.5)S 64 (0.5)S 32 (0.125)S 32 (0.5)S 64 (0.5)S 64 (0.5)S
NAE16 256 16 (0.062)S 32 (0.125)S 8 (0.031)S 16 (0.062)S 32 (0.125)S 32 (0.125)S 128 (0.5)S 128 (0.5)S
PA124 512 256 (0.5)S 256 (0.5)S 256 (0.5)S 256 (0.5)S 256 (0.5)S 256 (0.5)S 256 (0.5)S 256 (0.5)S
NOR AG100 16 16 (1)I 16 (1)I 4 (0.25)S 8 (0.5)S 8 (0.5)S 8 (0.5)S 16 (1)I 16 (1)I
EA27 16 128 (4)1 128 (4)1 8 (0.5)S 8 (0.5)S 2 (0.125)S 4 (0.25)S 8 (0.5)S 16 (1)I
CM64 128 256 (2)1 256 (2)1 8 (0.0625)S 16 (0.125)S 128 (1)I 128 (1)I 256 (2)1 256 (2)1
KP55 128 64 (0.5)S 64 (0.5)S 64 (0.5)S 64 (0.5)S 8 (0.0625)S 16 (0.125)S 64 (0.5)S 128 (1)I
KP63 8 32 (4)1 32 (4)1 4 (0.25)S 4 (0.25)S 8 (1)I 8 (1)I 8 (1)I 8 (1)I
NAE16 32 8 (0.25)S 16 (0.5)S 8 (0.25)S 8 (0.25)S 4 (0.125)S 4 (0.125)S 8 (0.25)S 8 (0.25)S
PA124 256 128 (0.5)S 128 (0.5)S 128 (0.5)S 128 (0.5)S 128 (0.5)S 128 (0.5)S 256 (1)1 256 (1)1
s: Synergy; I: Indifference; A: Antagonism; ( ): FIC values; -: MIC > 512 μg/mL or not determined FIC; ATB: Antibiotic; CIP: Ciprofloxacin, NOR: Norfloxacin, CHL:
Chloramphenicol, STR: Streptomycin, TET: Tetracycline, KAN: Kanamycin, ERY: Erythromycin, AMP: Ampicillin and CEF Cefepime; The values in bold represent
the cases of synergy between extract and antibiotic.
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fore be of limited importance. None-the-less, the obtained
results can be considered as interesting when considering
the fact that the extracts are obtained directly from edible
plant materials.
Efflux pumps are responsible for the reduction of intra-
cellular concentration of antibacterial compounds [29]. To
tackle problems related to this phenomenon, an intensive
search of efflux pumps inhibitors (EPI) is welcome [30].
The EPI blocks the efflux pumps and leads to the increase
of the intracellular concentration of active principle con-
tents of the extracts [29,31]. The activity of B. oleacera var.
butyris extract against the tested bacteria in the presence of
PAβN, increased in 75% of the cases. This suggests that
some compounds present in this extract could be substrates
of efflux pumps [31,32].
The extracts of B. oleacera var. butyris, B. oleracea var.
Italica, Basilicum polystachyon and C. frutescens showed
significant synergistic effects (0.031 < FIC < 0.5) with the
majority of the tested antibiotics against the studied MDR
strains. This suggests that the extracts might contain bio-
active compounds that, combined with antibiotics, acted at
different sites by various mechanisms [33,34]. These data
indicate that a combination of these extracts with antibi-
otics could be envisaged to fight MDR bacteria.Conclusion
These results provide promising baseline information for
the potential use of Capsicum frutescens, Brassica oleacera
var. italica, Basilicum polystachyon and Brassica oleacera
var. butyris, independently or in combination with some
commonly used antibiotics in the fight against MDR
Gram-negative bacteria.
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